Citius Oncology CTOR
NASDAQ CTOR
$0.70 +0.00 (+0.29%)
As of: Oct 22, 2026 · 9:33 AM EDT

Citius Oncology (CTOR) Other Non-Current Liabilities (2024 - 2026)

Updated

Citius Oncology (CTOR) reported Other Non-Current Liabilities of $559,015 for fiscal Q2 2026 (quarter ended Mar 31, 2026), unchanged from $559,015 a year earlier and unchanged from the prior quarter.

Analysis

Citius Oncology (CTOR) Other Non-Current Liabilities (2024 - 2026) Analysis & Trends

Dating back to fiscal Q1 2025, Citius Oncology's Other Non-Current Liabilities record includes 6 quarters.

  • Per Business Quant data, the three fiscal quarters before Q2 2026 came in at $559,015 (Q1 2026), $559,015 (Q4 2025) and $559,015 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,155.80 Bn 1,124.39 Bn 19.71 Bn
2 Johnson & Johnson 630.65 Bn 549.18 Bn 17.26 Bn
3 AbbVie 502.74 Bn 475.85 Bn 12.70 Bn
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn
5 Novartis Ag 301.36 Bn 265.35 Bn 11.24 Bn
6 Astrazeneca 265.02 Bn 238.70 Bn 12.86 Bn
7 Amgen 239.16 Bn 194.55 Bn 7.24 Bn
8 Gilead Sciences 192.63 Bn 166.82 Bn 6.22 Bn
9 Pfizer 171.82 Bn 118.47 Bn 10.94 Bn
10 Citius Oncology 75.77 Mn 45.35 Mn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 559,015.00
Dec 31, 2025 559,015.00
Sep 30, 2025 559,015.00
Jun 30, 2025 559,015.00
Mar 31, 2025 559,015.00
Dec 31, 2024 559,015.00
API Access

Citius Oncology Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CTOR&period=max&api_key=YOUR_API_KEY